Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.19 | 3e-05 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |